Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of freeze‑dried human rabies vaccine (serum‑free Vero cell) with different immunization schedules in persons aged 10–60 years
ChiCTR2300074062Phase 3Not yet recruiting
- Sponsor
- Sichuan Center for Disease Control and Prevention
- Start
- Jul 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of inactivated rabies vaccine in rabies (5 arms), sponsored by Sichuan Center for Disease Control and Prevention. Primary endpoints: SCR and GMC at day 14 after first dose (test 5-dose vs control 5-dose groups), SCR and GMC at day 14 after first dose (test 4-dose vs control 5-dose groups) and 2 more. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
inactivated rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on ChiCTR2300074062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074062.